Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Levinson

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Biorxiv : the Preprint Server for Biology|May 3, 2023
Allosteric coupling asymmetry mediates paradoxical activation of BRAF by type II inhibitorsDamien M Rasmussen, Manny M Semonis, Joseph T Greene, et al.
Elife|May 14, 2024
Allosteric coupling asymmetry mediates paradoxical activation of BRAF by type II inhibitorsDamien M Rasmussen, Manny M Semonis, Joseph T Greene, et al.
Elife|February 22, 2018
A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylationEmily F Ruff, Joseph M Muretta, Andrew R Thompson, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Journal of Extracellular Vesicles|October 9, 2025
Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular SubtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Discovery of 2H-Pyrrolo[3,4‑<i>c</i>]pyridin-3-one Derivatives as Type-III c‑MET Inhibitors Enabled by Free-Energy Perturbation CalculationsEric Therrien, Shulu Feng, Katherine Amberg-Johnson, et al.
ACS Medicinal Chemistry Letters|March 19, 2025
Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy Perturbation SimulationsAbba E Leffler, Evelyne M Houang, Felicia Gray, et al.
Journal of Medicinal Chemistry|January 26, 2023
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in MiceErik B Faber, Nan Wang, Kristen John, et al.
Nature Communications|June 3, 2023
Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin bindingErik B Faber, Luxin Sun, Jian Tang, et al.
Nature Communications|March 27, 2021
Bora phosphorylation substitutes in trans for T-loop phosphorylation in Aurora A to promote mitotic entryN Tavernier, Y Thomas, S Vigneron, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Biorxiv : the Preprint Server for Biology|May 3, 2023
Allosteric coupling asymmetry mediates paradoxical activation of BRAF by type II inhibitorsDamien M Rasmussen, Manny M Semonis, Joseph T Greene, et al.
Elife|May 14, 2024
Allosteric coupling asymmetry mediates paradoxical activation of BRAF by type II inhibitorsDamien M Rasmussen, Manny M Semonis, Joseph T Greene, et al.
Elife|February 22, 2018
A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylationEmily F Ruff, Joseph M Muretta, Andrew R Thompson, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Journal of Extracellular Vesicles|October 9, 2025
Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular SubtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Discovery of 2H-Pyrrolo[3,4‑<i>c</i>]pyridin-3-one Derivatives as Type-III c‑MET Inhibitors Enabled by Free-Energy Perturbation CalculationsEric Therrien, Shulu Feng, Katherine Amberg-Johnson, et al.
ACS Medicinal Chemistry Letters|March 19, 2025
Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy Perturbation SimulationsAbba E Leffler, Evelyne M Houang, Felicia Gray, et al.
Journal of Medicinal Chemistry|January 26, 2023
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in MiceErik B Faber, Nan Wang, Kristen John, et al.
Nature Communications|June 3, 2023
Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin bindingErik B Faber, Luxin Sun, Jian Tang, et al.
Nature Communications|March 27, 2021
Bora phosphorylation substitutes in trans for T-loop phosphorylation in Aurora A to promote mitotic entryN Tavernier, Y Thomas, S Vigneron, et al.
Pageof 19